Creating a better health environment in the Republic of Lithuania
The Lithuanian Good Clinical Practice (GCP) and Regulatory Affairs (RA) Association represents the pharmaceutical industry in Lithuania. We cooperate with Lithuanian and international organizations to foster and elevate the innovation, improvement and development of clinical trials‘ environment in Lithuania as well as globally. We are involved in GCP and RA policy making to create favourable conditions for the clinical research and registration process of the medical products.
1. The Association, which involves participants of the clinical drug development and regulatory process, aims to coordinate actions of the Association members, represents and protects the interests of its members, and serves other public interests.
2. The operational objective of the Association is to contribute to establishing favourable conditions for clinical trials and application of the good regulatory practice (GRP) in the process of pharmaceutical product registration in the Republic of Lithuania under the principles of ethics, good faith, and scientific approach and the Guidelines for Good Clinical Practice (GCP).
Briefly about our activities
Members of The Lithuanian GCP & RA Association are contract research organizations (CROs) and data science companies that represent and encourage advancement, innovation and the continued progress in the pharmaceutical, biotechnology, and medical device industries.
Become a member!
Contribute to the improvement and development of Good Clinical Practice and Regulatory Affairs.